OctPGMSGp pathway control state: Difference between revisions
From Bioblast
m (moved Pyruvate&GMSOctGp to PGMSOctGp) |
No edit summary |
||
| Line 8: | Line 8: | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT reference assay]] | |info=[[MiPNet21.06 SUIT reference assay]] | ||
}} | }} | ||
{{MitoPedia methods}} | {{MitoPedia methods}} | ||
{{MitoPedia | {{MitoPedia SUIT | ||
|mitopedia | |mitopedia SUIT=SUIT state | ||
}} | }} | ||
{{MitoPedia topics}} | |||
== PGMSOctGp(L) == | == PGMSOctGp(L) == | ||
Revision as of 15:32, 25 January 2016
- high-resolution terminology - matching measurements at high-resolution
OctPGMSGp pathway control state
Description
PGMSOctGp: Pyruvate & Glutamate & Malate & Succinate & Octanoylcarnitine & Glycerophosphate.
MitoPathway control: CI&II&FAO&GpDH
SUIT protocol: SUIT-RP2
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: PGMSOctGp
Reference: MiPNet21.06 SUIT reference assay
PGMSOctGp(L)
PGMSOctGp(P)
PGMSOctGp(E)
- SUIT-RP2_8Gp: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
